Tolerability and Safety Study of FLUVAL P Monovalent Influenza Vaccine in Children.
Phase of Trial: Phase II
Latest Information Update: 15 Sep 2017
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions
- Sponsors Fluart Innovative Vaccines; Omninvest
- 19 Oct 2011 ClinicalTrials.gov reports actual patients numbers (n=10).
- 19 Oct 2011 Status changed from active, no longer recruiting to completed on 1 May 2010 as reported by ClinicalTrials.gov.
- 09 Apr 2010 New trial record